Network

Nuno L. Figueiredo

  • Champalimaud Foundation
  • Fundação Champalimaud

External person

Geerard L. Beets

  • The Netherlands Cancer Institute
  • Maastricht University Medical Center+
  • Maastricht University

External person

Mireia Castillo-Martin

  • Champalimaud Centre for the Unknown
  • Fundação Champalimaud

External person

Angelita Habr-Gama

  • Angelita and Joaquim Gama Institute
  • Hospital Alemão Oswaldo Cruz

External person

Carine El Sissy

  • aboratory of Integrative Cancer Immunology, INSERM, Paris
  • Georges-Pompidou European Hospital
  • Université Paris 1 Panthéon-Sorbonne
  • Equipe Labellisée Ligue Contre le Cancer
  • French National Institute of Health
  • Equipe Labellisée Ligue Contre le Cancer
  • Pierre and Marie Curie University

External person

Christine Lagorce-Pagès

  • aboratory of Integrative Cancer Immunology, INSERM, Paris
  • Equipe Labellisée Ligue Contre le Cancer
  • Université Paris 1 Panthéon-Sorbonne
  • Georges-Pompidou European Hospital
  • French National Institute of Health

External person

Soledad Iseas

  • Hospital de Gastroenterología Dr. C. Bonorino Udaondo

External person

Rodrigo O. Perez

  • Angelita and Joaquim Gama Institute
  • Hospital Alemão Oswaldo Cruz & Hospital Beneficência Portuguesa de São Paulo
  • San Carlos Clinical Hospital
  • Hospital Alemão Oswaldo Cruz
  • Angelita and Joaquim Gama Institute

External person

Franck Pagès

  • aboratory of Integrative Cancer Immunology, INSERM, Paris
  • Equipe Labellisée Ligue Contre le Cancer
  • Maison de la Recherche, Université Paris I -Sorbonne,
  • Georges-Pompidou European Hospital
  • French National Institute of Health

External person

Amos Kirilovsky

  • aboratory of Integrative Cancer Immunology, INSERM, Paris
  • Equipe Labellisée Ligue Contre le Cancer
  • Université Paris 1 Panthéon-Sorbonne
  • Georges-Pompidou European Hospital
  • French National Institute of Health

External person

Guy Zeitoun

  • Georges-Pompidou European Hospital
  • French National Institute of Health

External person

Jean Pierre Gérard

  • Centre Antoine Lacassagne

External person

Mehdi Karoui

  • Université De Paris
  • Georges-Pompidou European Hospital

External person

Nacilla Haicheur

  • Georges-Pompidou European Hospital
  • French National Institute of Health

External person

Jérôme Galon

  • aboratory of Integrative Cancer Immunology, INSERM, Paris
  • Equipe Labellisée Ligue Contre le Cancer
  • Université Paris 1 Panthéon-Sorbonne
  • French National Institute of Health

External person

Myriam Chalabi

  • The Netherlands Cancer Institute

External person

Petra Custers

  • The Netherlands Cancer Institute
  • Maastricht University

External person

Florence Marliot

  • aboratory of Integrative Cancer Immunology, INSERM, Paris
  • Equipe Labellisée Ligue Contre le Cancer
  • Université Paris 1 Panthéon-Sorbonne
  • Georges-Pompidou European Hospital
  • French National Institute of Health

External person

Anna Cecilie Lefèvre

  • Aarhus University Hospital

External person

Mariana Coraglio

  • Hospital de Gastroenterología Dr. C. Bonorino Udaondo

External person

David Tougeron

  • Poitiers University Hospital

External person

Alfredo Romero

  • Hospital Británico

External person

Julien Taieb

  • Centre National de Référence des Mastocytoses

External person

Mihail Gabriel Dimofte

  • Regional Institute of Oncology (IRO)

External person

Malene Støchkel Frank

  • Næstved-Slagelse-Ringsted Hospitals
  • Zealand University Hospital, Roskilde
  • University of Copenhagen

External person

Carlos A Vaccaro

  • Hospital Italiano de Buenos Aires

External person

Fernando Sanchez Loria

  • Instituto Alexander Fleming

External person

Petra A. Custers

  • The Netherlands Cancer Institute
  • Maastricht University

External person

Christina Glismand Truelsen

  • Aarhus University Hospital

External person

Marine Sroussi

  • Pierre and Marie Curie University
  • University Psl

External person

Mohamed Dermani

  • French National Institute of Health

External person

Maria Gabriela Anitei

  • Gr. T. Popa University of Medicine and Pharmacy
  • Regional Institute of Oncology

External person

Nicolas Loche

  • French National Institute of Health

External person

Karen Lycke Wind

  • Aarhus University Hospital

External person

Viorel Scripcariu

  • Gr. T. Popa University of Medicine and Pharmacy

External person

Heidi Ryssel

  • University of Copenhagen
  • Rigshospitalet

External person

Juan Manuel O'Connor

  • Instituto Alexander Fleming

External person

Laura M. Fernandez

  • Fundação Champalimaud

External person

Pierre Laurent-Puig

  • Centre National de Référence des Mastocytoses
  • Georges-Pompidou European Hospital
  • French National Institute of Health
  • Pierre and Marie Curie University

External person

Laurids Østergaard Poulsen

  • Aalborg University
  • Aalborg University Hospital
  • Sygehus Lillebælt

External person

Aurélien De Reyniès

  • University Paris Cité
  • AP-HP)

External person

José G. Van Den Berg

  • The Netherlands Cancer Institute

External person

Juan P. Santino

  • Hospital Italiano de Buenos Aires

External person

Bénedicte Buttard

  • French National Institute of Health

External person

Louise Bach Callesen

  • Aarhus University Hospital
  • Aarhus University

External person

Annegien Broeks

  • The Netherlands Cancer Institute

External person

Ana Maria Musina

  • Regional Institute of Oncology (IRO)

External person